Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


11.03.2019

2 Ann Surg Oncol
3 Anticancer Res
4 BMC Cancer
1 Breast Cancer
2 Breast Cancer (Auckl)
3 Breast Cancer Res
9 Breast Cancer Res Treat
1 Breast J
3 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
6 Clin Breast Cancer
2 Clin Cancer Res
2 Eur J Surg Oncol
1 Int J Cancer
1 Int J Oncol
1 J Biol Chem
1 J Natl Cancer Inst
1 JAMA
4 Lancet Oncol
1 Nature
1 Oncogene
1 Oncol Rep
2 PLoS Genet
2 PLoS One
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. VAN BOMMEL A, Spronk P, Mureau M, Siesling S, et al
    Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-019-07265.
    PubMed     Text format     Abstract available

  2. WARNBERG F, Stigberg E, Obondo C, Olofsson H, et al
    Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-019-07239.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. LEWIN NL, Luetragoon T, Andersson BA, Oliva D, et al
    The Influence of Single Nucleotide Polymorphisms and Adjuvant Radiotherapy on Systemic Inflammatory Proteins, Chemokines and Cytokines of Patients With Breast Cancer.
    Anticancer Res. 2019;39:1287-1292.
    PubMed     Text format     Abstract available

  4. SHIMAZU K, Miyake T, Okuno J, Naoi Y, et al
    One-step Nucleic Acid Amplification Can Identify Sentinel Node-negative Breast Cancer Patients With Excellent Prognosis.
    Anticancer Res. 2019;39:1447-1454.
    PubMed     Text format     Abstract available

  5. VELLANKI SH, Cruz RGB, Richards CE, Smith YE, et al
    Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models.
    Anticancer Res. 2019;39:1197-1204.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. MATOSSIAN MD, Burks HE, Elliott S, Hoang VT, et al
    Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
    BMC Cancer. 2019;19:205.
    PubMed     Text format     Abstract available

  7. RODRIGUEZ-VELAZQUEZ A, Velez R, Lafontaine JC, Colon-Echevarria CB, et al
    Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico.
    BMC Cancer. 2018;18:1177.
    PubMed     Text format     Abstract available

  8. KATUWAL S, Tapanainen JS, Pukkala E, Kauppila A, et al
    The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
    BMC Cancer. 2019;19:199.
    PubMed     Text format     Abstract available

  9. NARANG P, Chen M, Sharma AA, Anderson KS, et al
    The neoepitope landscape of breast cancer: implications for immunotherapy.
    BMC Cancer. 2019;19:200.
    PubMed     Text format     Abstract available


    Breast Cancer

  10. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 4. pii: 10.1007/s12282-019-00957.
    PubMed     Text format     Abstract available


    Breast Cancer (Auckl)

  11. PURNELL MC
    Bio-Field Array: The Influence of Junction Mediating and Regulatory Protein Expression on Cytoskeletal Filament Behavior During Apoptosis in Triple-Negative Breast Cancer.
    Breast Cancer (Auckl). 2019;13:1178223419830981.
    PubMed     Text format     Abstract available

  12. YAZDANI A, Dorri S, Atashi A, Shirafkan H, et al
    Bone Metastasis Prognostic Factors in Breast Cancer.
    Breast Cancer (Auckl). 2019;13:1178223419830978.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  13. GARCIA-ESTEVEZ L, Moreno-Bueno G
    Updating the role of obesity and cholesterol in breast cancer.
    Breast Cancer Res. 2019;21:35.
    PubMed     Text format     Abstract available

  14. ALZUBI MA, Turner TH, Olex AL, Sohal SS, et al
    Separation of breast cancer and organ microenvironment transcriptomes in metastases.
    Breast Cancer Res. 2019;21:36.
    PubMed     Text format     Abstract available

  15. VIJAY GV, Zhao N, Den Hollander P, Toneff MJ, et al
    GSK3beta regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Breast Cancer Res. 2019;21:37.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  16. DOEGE D, Thong MS, Koch-Gallenkamp L, Bertram H, et al
    Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany.
    Breast Cancer Res Treat. 2019 Mar 2. pii: 10.1007/s10549-019-05188.
    PubMed     Text format     Abstract available

  17. PLAVC G, Ratosa I, Zagar T, Zadnik V, et al
    Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia.
    Breast Cancer Res Treat. 2019 Mar 7. pii: 10.1007/s10549-019-05186.
    PubMed     Text format     Abstract available

  18. ZHANG B, Long EF
    Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer.
    Breast Cancer Res Treat. 2019 Mar 7. pii: 10.1007/s10549-019-05190.
    PubMed     Text format     Abstract available

  19. KAISER K, Cameron KA, Beaumont J, Garcia SF, et al
    What does risk of future cancer mean to breast cancer patients?
    Breast Cancer Res Treat. 2019 Mar 6. pii: 10.1007/s10549-019-05182.
    PubMed     Text format     Abstract available

  20. WANG Z, Katsaros D, Biglia N, Shen Y, et al
    ERalpha upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-kappaB in breast cancer.
    Breast Cancer Res Treat. 2019 Mar 4. pii: 10.1007/s10549-018-05108.
    PubMed     Text format     Abstract available

  21. MCMULLEN ER, Gonzalez ME, Skala SL, Tran M, et al
    CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast.
    Breast Cancer Res Treat. 2018;172:577-586.
    PubMed     Text format     Abstract available

  22. MCCLATCHY DM 3RD, Zuurbier RA, Wells WA, Paulsen KD, et al
    Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology.
    Breast Cancer Res Treat. 2018;172:587-595.
    PubMed     Text format     Abstract available

  23. VAN DOOIJEWEERT C, Deckers IAG, Baas IO, van der Wall E, et al
    Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands.
    Breast Cancer Res Treat. 2019 Mar 1. pii: 10.1007/s10549-019-05180.
    PubMed     Text format     Abstract available

  24. LEE J, Lim B, Pearson T, Choi K, et al
    Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
    Breast Cancer Res Treat. 2019 Mar 2. pii: 10.1007/s10549-019-05166.
    PubMed     Text format     Abstract available


    Breast J

  25. ANAMPA JD, McEvoy MP, Feldman S, Sparano JA, et al
    Applying the Hippocratic Oath in breast cancer-The case for promoting prevention.
    Breast J. 2019;25:187-189.
    PubMed     Text format    


    Cancer

  26. BAGLIA ML, Lin IH, Cartmel B, Sanft T, et al
    Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32051.
    PubMed     Text format     Abstract available

  27. PRINTZ C
    Study projects a 43% increase in lung cancer mortality among women: New research suggests that, among women, strides in reducing global deaths from breast cancer could be tempered by rising lung cancer deaths. However, according to experts, the projec
    Cancer. 2019;125:831-832.
    PubMed     Text format    

  28. DEAN LT, Moss SL, Rollinson SI, Frasso Jaramillo L, et al
    Patient recommendations for reducing long-lasting economic burden after breast cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32012.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  29. KJAERULFF TM, Ersboll AK, Green A, Emneus M, et al
    Finasteride use and risk of male breast cancer: a case-control study using individual-level registry data from Denmark, Finland, and Sweden.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. pii: 1055-9965.EPI-18-0904.
    PubMed     Text format     Abstract available


    Cancer Res

  30. YAMAMOTO M, Jin C, Hata T, Yasumizu Y, et al
    MUC1-C INTEGRATES CHROMATIN REMODELING AND PARP1 ACTIVITY IN THE DNA DAMAGE RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER CELLS.
    Cancer Res. 2019 Mar 1. pii: 0008-5472.CAN-18-3259.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  31. XIE Y, Li Y, Zhang Y, Zhang S, et al
    Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30801.
    PubMed     Text format     Abstract available

  32. KLAR N, Rosenzweig M, Diergaarde B, Brufsky A, et al
    Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30853.
    PubMed     Text format     Abstract available

  33. TANGALAKIS LL, Cortina CS, Son JD, Poirier J, et al
    Obesity Does Not Influence Management of Advanced Breast Cancer in the Elderly.
    Clin Breast Cancer. 2019 Jan 12. pii: S1526-8209(18)30520.
    PubMed     Text format     Abstract available

  34. ARCIERO CA, Guo Y, Jiang R, Behera M, et al
    ER(+)/HER2(+) Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2(+) Breast Cancer.
    Clin Breast Cancer. 2019 Feb 14. pii: S1526-8209(18)30792.
    PubMed     Text format     Abstract available

  35. TANG Y, Wang Y, Wang X, Liu Y, et al
    A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30454.
    PubMed     Text format     Abstract available

  36. HEMIDA MA, AbdElmoneim NA, Hewala TI, Rashad MM, et al
    Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-alpha) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30224.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  37. XIAO Y, Ma D, Zhao S, Suo C, et al
    Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer.
    Clin Cancer Res. 2019 Mar 5. pii: 1078-0432.CCR-18-3524.
    PubMed     Text format     Abstract available

  38. LIU Z, Li Z, Qu J, Zhang R, et al
    Radiomics of multi-parametric MRI for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
    Clin Cancer Res. 2019 Mar 6. pii: 1078-0432.CCR-18-3190.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  39. WANG K, Shi Y, Li ZY, Xiao YL, et al
    Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
    Eur J Surg Oncol. 2019 Feb 19. pii: S0748-7983(19)30283.
    PubMed     Text format     Abstract available

  40. VAN BOCKSTAL MR, Monstrey SJ, van Deurzen CHM
    The role of routine histopathology after chest-contouring surgery in transmen.
    Eur J Surg Oncol. 2019;45:485-486.
    PubMed     Text format    


    Int J Cancer

  41. GIULIANELLI S, Riggio M, Guillardoy T, Perez Pinero C, et al
    FGF2 Induces Breast Cancer Growth through Ligand-Independent Activation and Recruitment of ERalpha and PRB4 Isoform to MYC Regulatory Sequences.
    Int J Cancer. 2019 Mar 7. doi: 10.1002/ijc.32252.
    PubMed     Text format     Abstract available


    Int J Oncol

  42. LUPICKI K, Elifio-Esposito S, Fonseca AS, Weber SH, et al
    Patterns of copy number alterations in primary breast tumors of South African patients and their impact on functional cellular pathways.
    Int J Oncol. 2018;53:2745-2757.
    PubMed     Text format     Abstract available


    J Biol Chem

  43. DAS A, Narayanam MK, Paul S, Mukherjee P, et al
    A novel triazole NMK-T-057 induces autophagic cell death in breast cancer cells by inhibiting gamma-secretase-mediated activation of Notch-signaling.
    J Biol Chem. 2019 Mar 1. pii: RA119.007671. doi: 10.1074/jbc.RA119.007671.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  44. RODRIGUEZ-RUIZ A, Lang K, Gubern-Merida A, Broeders M, et al
    Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists.
    J Natl Cancer Inst. 2019 Mar 5. pii: 5307077. doi: 10.1093.
    PubMed     Text format     Abstract available


    JAMA

  45. DOMCHEK SM
    Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion.
    JAMA. 2019;321:27.
    PubMed     Text format    


    Lancet Oncol

  46. CATANIA G, Ghirotto L, Leo SD, Timmins F, et al
    What a picture can tell you about surviving breast cancer.
    Lancet Oncol. 2019;20:335.
    PubMed     Text format    

  47. ESTEVA FJ, Hubbard-Lucey VM, Tang J, Pusztai L, et al
    Immunotherapy and targeted therapy combinations in metastatic breast cancer.
    Lancet Oncol. 2019;20:e175-e186.
    PubMed     Text format     Abstract available

  48. CHAE SY, Ahn SH, Kim SB, Han S, et al
    Diagnostic accuracy and safety of 16alpha-[(18)F]fluoro-17beta-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study.
    Lancet Oncol. 2019 Mar 4. pii: S1470-2045(18)30936.
    PubMed     Text format     Abstract available

  49. STIRRUPS R
    Sacituzumab govitecan-hziy for triple-negative breast cancer.
    Lancet Oncol. 2019 Feb 28. pii: S1470-2045(19)30074.
    PubMed     Text format    


    Nature

  50. LEE J, Yesilkanal AE, Wynne JP, Frankenberger C, et al
    Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.
    Nature. 2019 Mar 6. pii: 10.1038/s41586-019-1005.
    PubMed     Text format     Abstract available


    Oncogene

  51. INESS AN, Felthousen J, Ananthapadmanabhan V, Sesay F, et al
    The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Oncogene. 2019;38:1080-1092.
    PubMed     Text format     Abstract available


    Oncol Rep

  52. LU S, Du Y, Cui F, Feng X, et al
    Downregulation of BAG1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.
    Oncol Rep. 2019;41:1901-1910.
    PubMed     Text format     Abstract available


    PLoS Genet

  53. CLINE MS, Liao RG, Parsons MT, Paten B, et al
    BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
    PLoS Genet. 2018;14:e1007752.
    PubMed     Text format     Abstract available

  54. WILK G, Braun R
    regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
    PLoS Genet. 2018;14:e1007837.
    PubMed     Text format     Abstract available


    PLoS One

  55. JIANG X, Wells A, Brufsky A, Neapolitan R, et al
    A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis.
    PLoS One. 2019;14:e0213292.
    PubMed     Text format     Abstract available

  56. SERGANOVA I, Cohen IJ, Vemuri K, Shindo M, et al
    LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response.
    PLoS One. 2018;13:e0203965.
    PubMed     Text format     Abstract available


    Radiother Oncol

  57. HAQUE W, Verma V, Farach A, Brian Butler E, et al
    Postmastectomy radiation therapy for triple negative, node-negative breast cancer.
    Radiother Oncol. 2019;132:48-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: